Moore Capital Management, LP Biomarin Pharmaceutical Inc Call Options Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $1.26 Million - $1.49 Million
15,000 Added 20.0%
90,000 $7.86 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $5.72 Million - $7.39 Million
75,000 New
75,000 $7.23 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $2.6 Million - $3.01 Million
30,000 New
30,000 $2.6 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email